High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Testing the Use of an IDH1 Inhibitor, Olutasidenib, in Acute Myeloid Leukemia Added to ASTX727 and Venetoclax; in High-Risk MDS Added to ASTX727; and Alone in Low Risk MDS (A MyeloMATCH Treatment Substudy)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Evaluation of Chemotherapy-induced Cognitive Disorders During the Treatment of Hematological Malignancies
- Status
- RECRUITING
- Phase
- N/A
Expression Pattern and Possible Clinical Significance of CD81 In Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Donor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Olutasidenib Single Plus Combo Therapy in IDH1mut AML After Induction and Consolidation
- Status
- RECRUITING
- Phase
- PHASE1
Home Blood Transfusions
- Status
- RECRUITING
- Phase
- NA
Molecular Characterization of Carbapenemase-Producing Enterobacterales
- Status
- NOT_YET_RECRUITING
- Phase
- NA
The Prognostic Significance of Platelet to White Blood Cell Ratio (PWR) in Patients With Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Efficacy of Integrated Induction-Consolidation Chemotherapy and Transplantation for Adult Acute Myeloid Leukemia: Multicenter Study
- Status
- RECRUITING
- Phase
- PHASE2
Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes
- Status
- RECRUITING
- Phase
- PHASE1
CD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Observational Study on APL-like aCute Myeloid Leukemia: disTInct Phenotype and Early VAscular complicaTions
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Venetoclax-containing Therapy Combined With Microtransplant for Newly Diagnosed AML
- Status
- RECRUITING
- Phase
- PHASE2
Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE3
Repurposing Itraconazole as an Adjuvant Therapy in Treatment of Patients With Acute Myeloid Leukemia: Is it a Hopeful Avenue for Enhancing Treatment Options?
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer
- Status
- RECRUITING
- Phase
- PHASE2